Upstream Bio UPB
NASDAQ UPB
$6.01 -0.07 (-1.15%)
As of: Sep 4, 2026 · 3:59 PM EDT

Upstream Bio (UPB) Other Working Capital Changes (2023 - 2026)

Upstream Bio (UPB) posted quarterly Other Working Capital Changes of -$155000.0 for Q1 2026, down 15.67% year-over-year from -$183805.3 in Q1 2025, and down 3.33% quarter-over-quarter from -$150000.0 in Q4 2025.

Analysis

Upstream Bio (UPB) Other Working Capital Changes (2023 - 2026) Analysis & Trends

Upstream Bio's Other Working Capital Changes history runs 4 years deep, the most recent figure standing at -$155000.0 for Q1 2026.

  • In Q1 2026, Other Working Capital Changes fell 15.67% year-over-year to -$155000.0; the TTM figure through Mar 2026 stood at -$586000.0 (down 139.18% YoY), while the FY2025 annual figure was -$565000.0, down 324.81% from the prior year.
  • Other Working Capital Changes for Q1 2026 stood at -$155000.0, down from -$150000.0 in the prior quarter.
  • The five-year high for Other Working Capital Changes was $13.7 million in Q1 2025, with the low at -$7.8 million in Q3 2025.
  • The 4-year median for Other Working Capital Changes is $1.8 million (2024), against an average of $1.9 million.
  • The sharpest annual moves came in 2025 and 2026: Other Working Capital Changes slumped 847.37% in 2025, then declined 15.67% in 2026.
  • Upstream Bio's Other Working Capital Changes stood at -$20000.0 in 2023, then slumped by 435.0% to -$107000.0 in 2024, then tumbled by 40.19% to -$150000.0 in 2025, then fell by 3.33% to -$155000.0 in 2026.
  • Business Quant data shows UPB's Other Working Capital Changes at -$155000.0 in Q1 2026, -$150000.0 in Q4 2025, and -$142000.0 in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Upstream Bio 327.95 Mn 327.95 Mn -3.29 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -3.14 Mn
Jun 30, 2026 -3.14 Mn
Mar 31, 2026 11.05 Mn
Mar 31, 2026 11.05 Mn
Dec 31, 2025 -6.29 Mn
Dec 31, 2025 -6.29 Mn
Sep 30, 2025 -7.85 Mn
Sep 30, 2025 -7.85 Mn
Jun 30, 2025 1.91 Mn
Jun 30, 2025 1.91 Mn
Mar 31, 2025 13.75 Mn
Mar 31, 2025 13.75 Mn
Dec 31, 2024 2.09 Mn
Dec 31, 2024 2.09 Mn
Sep 30, 2024 -710,000.00
Sep 30, 2024 -710,000.00
Jun 30, 2024 -2.07 Mn
Jun 30, 2024 -2.07 Mn
Mar 31, 2024 1.70 Mn
Mar 31, 2024 1.70 Mn